genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Cancer

      How Incurable Melanoma Resists Treatment

      Rodeo
      AgBio

      Food For Thought: Final Report from the AGBT Ag Meeting

      Cancer

      Molecular Time Travel Helps Colon Cells Turn Cancerous

      Autism, puzzle pieces and brain
      Autism

      Amino Acid Deficit Impacts Perinatal Mouse Brain Development, Leading to Microcephaly,…

      Drug Delivery

      Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Base Editing

      One-Time Treatment: Base Editing Shows Promise vs. SMA

      Drug Delivery

      Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein…

      Bioprocessing

      Polymer Formulation to Improve Existing Antibiotics

      Bioprocessing

      Key Consideration for Going Digital

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home RNA miRNA Page 3

miRNA

  • Antisense
  • Gene Silencing
  • lncRNA
  • miRNA
  • mRNA
  • RNAi
  • shRNA
    Random
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    miRNA

    Regulus Therapeutics Spun Out of Isis and Alnylam to Focus on miRNA Drugs

    miRNA

    Regulus Therapeutics and Duke Univ. Find that Viral miRNAs Mimic Human miRNAs

    miRNA

    GSK to Pay Regulus $20M Upfront in Inflammatory Disease Deal

    miRNA

    Regulus Licenses miRNA Antagonist IP from Stanford University

    miRNA

    Regulus Raises $20M in Series A Round

    Findings were used to turn skin cells into iPSCs more efficiently. [© juggle33 - Fotolia.com]
    miRNA

    Researchers Identify miRNAs Involved in Cellular Reprogramming

    miRNA

    Ariadne Licenses Data Mining and Visualization Tool to Georgetown University

    miRNA

    Santaris Pharma Licenses miRNA from MGH for Development in Cardiovascular Diseases

    miRNA

    Integrated DNA Technologies to Custom Manufacture Quanta Biosciences’ miRNA Assays

    miRNA

    Regulus Licenses miR-33a and miR-33b Therapeutic IP from NYU

    miRNA

    Scientists Find miRNA Involved in Obesity-Induced Insulin Resistance

    miRNA

    Scientists Identify Genetic Markers for Early Prostate Cancer in African-Americans

    miRNA

    Scientists Use miRNAs to Improve Efficiency of Generating iPSCs Without Transcription...

    University grant-funded collaboration will exploit Regulus miRNA platform with UCSD’s expertise in angiogenesis models.[© Dario Bajurin - Fotolia.com]
    miRNA

    Regulus and UCSD Partner to Develop miRNA-Targeting Anti-Angiogenesis Therapeutics

    Collaboration will use SistemQC platform to help ensure standardization of cells for clinical applications.[© jscreationzs - Fotolia.com]
    miRNA

    Roslin Cells and Sistemic to Develop miRNA-Based Tools for Monitoring Stem...

    1234...14Page 3 of 14

    Recently Featured

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    One-Time Treatment: Base Editing Shows Promise vs. SMA

    How Incurable Melanoma Resists Treatment

    How Incurable Melanoma Resists Treatment

    Molecular Time Travel Helps Colon Cells Turn Cancerous

    Molecular Time Travel Helps Colon Cells Turn Cancerous

    Amino Acid Deficit Impacts Perinatal Mouse Brain Development, Leading to Microcephaly, Autism Behaviors

    Amino Acid Deficit Impacts Perinatal Mouse Brain Development, Leading to Microcephaly, Autism Behaviors

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up